Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis P Garrison

Showing results (11-20 of 190) with videos related to

Pageof 19
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 23, 2022
Is the world ready for gene therapy?Louis P Garrison, Diane Kleinermans
Pharmacoeconomics|February 4, 2024
Incorporating Real Option Value in Valuing Innovation: A Way ForwardMeng Li, Louis P Garrison
Journal of Personalized Medicine|September 5, 2017
Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health EconomicsLouis P Garrison, Adrian Towse
Expert Review of Pharmacoeconomics & Outcomes Research|March 1, 2021
The challenge of value-based pricing in combination therapy: the case of trastuzumab and pertuzumab in HER2+ metastatic breast cancerBoshen Jiao, Louis P Garrison
Journal of Managed Care & Specialty Pharmacy|September 27, 2019
A Strategy to Support Efficient Development and Use of Innovations in Personalized Medicine and Precision MedicineLouis P Garrison, Adrian Towse
Pharmacoeconomics|January 21, 2010
Can't get no satisfaction? Will pay for performance help?: toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical productsAdrian Towse, Louis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2013
Economic incentives for evidence generation: promoting an efficient path to personalized medicineAdrian Towse, Louis P Garrison
Health Affairs (Project Hope)|March 9, 2006
Implications of Part D for mentally ill dual eligibles: a challenge for MedicareNancy E Morden, Louis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 13, 2010
Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the US and Other CountriesAdrian R Levy, Louis P Garrison
Expert Review of Pharmacoeconomics & Outcomes Research|April 14, 2010
Economic evaluation of capecitabine as adjuvant or metastatic therapy in colorectal cancerJennie H Best, Louis P Garrison
Pageof 19

Showing results (11-20 of 190) with videos related to

Sort By:
Pageof 19
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 23, 2022
Is the world ready for gene therapy?Louis P Garrison, Diane Kleinermans
Pharmacoeconomics|February 4, 2024
Incorporating Real Option Value in Valuing Innovation: A Way ForwardMeng Li, Louis P Garrison
Journal of Personalized Medicine|September 5, 2017
Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health EconomicsLouis P Garrison, Adrian Towse
Expert Review of Pharmacoeconomics & Outcomes Research|March 1, 2021
The challenge of value-based pricing in combination therapy: the case of trastuzumab and pertuzumab in HER2+ metastatic breast cancerBoshen Jiao, Louis P Garrison
Journal of Managed Care & Specialty Pharmacy|September 27, 2019
A Strategy to Support Efficient Development and Use of Innovations in Personalized Medicine and Precision MedicineLouis P Garrison, Adrian Towse
Pharmacoeconomics|January 21, 2010
Can't get no satisfaction? Will pay for performance help?: toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical productsAdrian Towse, Louis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2013
Economic incentives for evidence generation: promoting an efficient path to personalized medicineAdrian Towse, Louis P Garrison
Health Affairs (Project Hope)|March 9, 2006
Implications of Part D for mentally ill dual eligibles: a challenge for MedicareNancy E Morden, Louis P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 13, 2010
Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the US and Other CountriesAdrian R Levy, Louis P Garrison
Expert Review of Pharmacoeconomics & Outcomes Research|April 14, 2010
Economic evaluation of capecitabine as adjuvant or metastatic therapy in colorectal cancerJennie H Best, Louis P Garrison
Pageof 19